COMPANY

Arsenal Medical, Inc.

HQ: Waltham, MA source · arsenalmedical.com ↗ · New England

Also known as Arsenal Medical · 10 sources

Keywords: women's health Subdural Hematoma Hemorrhagic Shock Trauma Exsanguinating Hemorrhage ResQFoam

Location: Waltham, MA · source · Oct 15, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

NIH award NIH awarded $2.24M (SBIR commercialization 1SB1AG102149-01, new, notice Sep 18, 2026). NIH RePORTER 1SB1AG102149-01 (Sep 18, 2026)
Evidence (1 event)
- Sep 18, 2026 · NIH RePORTER 1SB1AG102149-01
  Organization: ARSENAL MEDICAL, INC.; City/State: Waltham, MA; Project number: 1SB1AG102149-01; Activity code: SB1; Fiscal year: 2026; Award notice date: 2026-09-18; FY total cost (award amount): 2238626; Administering IC: National Institute on Aging; Project title: RADIANT: A Pivotal Clinical Study of a Next-Generation Embolic for Chronic Subdural Hematoma; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Sep 18, 2026 Grant Government grant — SBIR: $2.24M (annual award, as published), announced Sep 18, 2026. Agency: NIH/NIA. Source: government award database. source ↗
Aug 13, 2026 Trial start Not phased (device or behavioral study): MMA Embolization With NeoCast for Subacute and Chronic Subdural Hematoma source ↗
Aug 7, 2025 Trial start Not phased (device or behavioral study): REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam source ↗
Jul 30, 2025 Grant Government grant — SBIR: $314,363 (annual award, as published), announced Jul 30, 2025. Agency: NIH/NINDS. Source: government award database. source ↗

Oct 31, 2026 (ESTIMATED) · Not phased · REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam · NCT02880163
2028-01 (ESTIMATED) · Not phased · MMA Embolization With NeoCast for Subacute and Chronic Subdural Hematoma · NCT07541404

Estimated primary completion per ClinicalTrials.gov. Dates move.

Last 2 years.

Sep 18, 2026 Government grant — SBIR: $2.24M (annual award, as published), announced Sep 18, 2026. Agency: NIH/NIA. Source: government award database. source ↗
Jul 30, 2025 Government grant — SBIR: $314,363 (annual award, as published), announced Jul 30, 2025. Agency: NIH/NINDS. Source: government award database. source ↗

Record	Title	Phase	Status	Start	Primary completion
NCT07541404	MMA Embolization With NeoCast for Subacute and Chronic Subdural Hematoma	Not phased (device or behavioral study)	Recruiting	Aug 13, 2026	2028-01 (estimated)
NCT02880163	REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam	Not phased (device or behavioral study)	Recruiting	Aug 7, 2025	Oct 31, 2026 (estimated)

Annual award amounts. Total $4.0M.

Jan 14, 2022 NIH award 5R44CA257802-02 FY2022: $1,117,374 awarded for that fiscal year; activity R44 (SBIR); PI PHAM, QUYNH P; recipient as written: ARSENAL MEDICAL, INC., Waltham, MA. Flow Responsive Embolic Agent for the Comple source ↗
May 13, 2021 NIH award 1R44CA257802-01A1 FY2021: $791,378 awarded for that fiscal year; activity R44 (SBIR); PI PHAM, QUYNH P; recipient as written: ARSENAL MEDICAL, INC., Waltham, MA. Flow Responsive Embolic Agent for the Comple source ↗
Jul 23, 2020 NIH award 1R43HL154865-01 FY2020: $367,201 awarded for that fiscal year; activity R43 (SBIR); PI PHAM, QUYNH P; recipient as written: ARSENAL MEDICAL, INC., Waltham, MA. Ideal Embolic for Portal Vein Embolization source ↗
Jul 26, 2018 NIH award 5R44GM117849-03 FY2018: $762,094 awarded for that fiscal year; activity R44 (SBIR); PI PHAM, QUYNH P; recipient as written: ARSENAL MEDICAL, INC., Waltham, MA. Development of Self-Expanding Foams for Percut source ↗
Apr 5, 2017 NIH award 4R44GM117849-02 FY2017: $762,094 awarded for that fiscal year; activity R44 (SBIR); PI SHARMA, UPMA; recipient as written: ARSENAL MEDICAL, INC., Waltham, MA. Development of Self-Expanding Foams for Percuta source ↗
Aug 26, 2016 NIH award 1R44GM117849-01 FY2016: $227,667 awarded for that fiscal year; activity R44 (SBIR); PI SHARMA, UPMA; recipient as written: ARSENAL MEDICAL, INC., Waltham, MA. Development of Self-Expanding Foams for Percuta source ↗